84 related articles for article (PubMed ID: 33824482)
1. Correction: IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src/FAK signalling in hepatocellular carcinoma.
Mo CF; Li J; Yang SX; Guo HJ; Liu Y; Luo XY; Wang YT; Li MH; Li JY; Zou Q
Br J Cancer; 2021 May; 124(11):1895. PubMed ID: 33824482
[No Abstract] [Full Text] [Related]
2. IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src/FAK signalling in hepatocellular carcinoma.
Mo CF; Li J; Yang SX; Guo HJ; Liu Y; Luo XY; Wang YT; Li MH; Li JY; Zou Q
Br J Cancer; 2020 Sep; 123(7):1154-1163. PubMed ID: 32632148
[TBL] [Abstract][Full Text] [Related]
3. Correction: IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src/FAK signalling in hepatocellular carcinoma.
Mo CF; Li J; Yang SX; Guo HJ; Liu Y; Luo XY; Wang YT; Li MH; Li JY; Zou Q
Br J Cancer; 2021 Aug; 125(4):622. PubMed ID: 34112953
[No Abstract] [Full Text] [Related]
4. ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma.
Li K; Zhao G; Ao J; Gong D; Zhang J; Chen Y; Li J; Huang L; Xiang R; Hu J; Lin P; Wei Y
Cancer Lett; 2019 Feb; 442():271-278. PubMed ID: 30439540
[TBL] [Abstract][Full Text] [Related]
5. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J
J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955
[TBL] [Abstract][Full Text] [Related]
6. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.
Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S
Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694
[TBL] [Abstract][Full Text] [Related]
8. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
9. MeHg affects the activation of FAK, Src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells.
Hernández AJA; Reyes VL; Albores-García D; Gómez R; Calderón-Aranda ES
Toxicology; 2018 Feb; 394():35-44. PubMed ID: 29197552
[TBL] [Abstract][Full Text] [Related]
10. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
11. CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells.
Wang SJ; Cui HY; Liu YM; Zhao P; Zhang Y; Fu ZG; Chen ZN; Jiang JL
Oncotarget; 2015 Jan; 6(1):243-57. PubMed ID: 25428919
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Surgery; 2004 May; 135(5):555-62. PubMed ID: 15118593
[TBL] [Abstract][Full Text] [Related]
13. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling.
Chen IH; Shih HC; Hsieh PW; Chang FR; Wu YC; Wu CC
Toxicol Appl Pharmacol; 2015 Dec; 289(2):330-40. PubMed ID: 26386190
[TBL] [Abstract][Full Text] [Related]
14. PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation.
Díaz-Montero CM; Wygant JN; McIntyre BW
Eur J Cancer; 2006 Jul; 42(10):1491-500. PubMed ID: 16759849
[TBL] [Abstract][Full Text] [Related]
15. Integrin alpha3beta1-dependent activation of FAK/Src regulates Rac1-mediated keratinocyte polarization on laminin-5.
Choma DP; Milano V; Pumiglia KM; DiPersio CM
J Invest Dermatol; 2007 Jan; 127(1):31-40. PubMed ID: 16917494
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts.
Horowitz JC; Rogers DS; Sharma V; Vittal R; White ES; Cui Z; Thannickal VJ
Cell Signal; 2007 Apr; 19(4):761-71. PubMed ID: 17113264
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma.
Zhu HD; Liu L; Deng H; Li ZB; Sheng JQ; He XX; Tian DA; Li PY
J Cell Physiol; 2020 Jun; 235(6):5084-5095. PubMed ID: 31691973
[TBL] [Abstract][Full Text] [Related]
18. B1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms.
Bouchard V; Harnois C; Demers MJ; Thibodeau S; Laquerre V; Gauthier R; Vézina A; Noël D; Fujita N; Tsuruo T; Arguin M; Vachon PH
Apoptosis; 2008 Apr; 13(4):531-42. PubMed ID: 18322799
[TBL] [Abstract][Full Text] [Related]
19. Delayed caspase-8 activation and enhanced integrin β1-activated FAK underpins anoikis in oesophageal carcinoma cells harbouring mt p53-R175H.
Fanucchi S; Veale RB
Cell Biol Int; 2011 Aug; 35(8):819-26. PubMed ID: 21426305
[TBL] [Abstract][Full Text] [Related]
20. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells.
Sun B; Hu C; Yang Z; Zhang X; Zhao L; Xiong J; Ma J; Chen L; Qian H; Luo X; Shi L; Li J; Cheng X; Yin Z
Oncotarget; 2017 May; 8(20):32523-32535. PubMed ID: 28430645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
